Skip to main content

Navigation group

Type at least 3 characters
709 articles

Articles

Methods

Published on 05 Jul 2022

Implementing Pharmacogenetic Testing in Gastrointestinal Cancers (IMPACT-GI): Study Protocol for a Pragmatic Implementation Trial for Establishing DPYD and UGT1A1 Screening to Guide Chemotherapy Dosing

in Gastrointestinal Cancers: Colorectal Cancer

  • Lisa A. Varughese
  • Madhuri Bhupathiraju
  • Glenda Hoffecker
  • Shannon Terek
  • Margaret Harr
  • Hakon Hakonarson
  • Christine Cambareri
  • Jessica Marini
  • Jeffrey Landgraf
  • Jinbo Chen
Implementing Pharmacogenetic Testing in Gastrointestinal Cancers (IMPACT-GI): Study Protocol for a Pragmatic Implementation Trial for Establishing DPYD and UGT1A1 Screening to Guide Chemotherapy Dosing
Frontiers in Oncology
doi 10.3389/fonc.2022.859846
  • 4,512 views
  • 8 citations

Original Research

Published on 28 Jun 2022

A Pilot, Prospective, Observational Study to Investigate the Value of NGS in Liquid Biopsies to Predict Tumor Response After Neoadjuvant Chemo-Radiotherapy in Patients With Locally Advanced Rectal Cancer: The LiBReCa Study

in Gastrointestinal Cancers: Colorectal Cancer

  • Raffaello Roesel
  • Samantha Epistolio
  • Francesca Molinari
  • Piercarlo Saletti
  • Sara De Dosso
  • Mariacarla Valli
  • Alessandra Franzetti-Pellanda
  • Letizia Deantonio
  • Maira Biggiogero
  • Paolo Spina
A Pilot, Prospective, Observational Study to Investigate the Value of NGS in Liquid Biopsies to Predict Tumor Response After Neoadjuvant Chemo-Radiotherapy in Patients With Locally Advanced Rectal Cancer: The LiBReCa Study
Frontiers in Oncology
doi 10.3389/fonc.2022.900945
  • 2,944 views
  • 9 citations